4577
Daito Pharmaceutical Co.,Ltd.
ダイト
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsSep 1, 2023 Stock split 1 share → 1.1 shares
Key metrics
Revenue(million JPY)
May 2021
48,715
May 2022
43,464
May 2023
45,101
May 2024
46,895
May 2025
50,643
Operating profit(million JPY)
May 2021
5,909
May 2022
6,553
May 2023
5,207
May 2024
3,894
May 2025
2,619
Operating profit margin(%)
May 2021
12.13
May 2022
15.08
May 2023
11.55
May 2024
8.3
May 2025
5.17
Profit before tax(million JPY)
May 2021
5,874
May 2022
6,720
May 2023
5,076
May 2024
4,218
May 2025
2,958
Profit(million JPY)
May 2021
4,246
May 2022
4,668
May 2023
3,600
May 2024
3,295
May 2025
1,908
Total assets(million JPY)
May 2021
57,739
May 2022
64,939
May 2023
70,552
May 2024
77,708
May 2025
78,004
Cash and cash equivalents(million JPY)
May 2021
3,373
May 2022
4,381
May 2023
3,607
May 2024
2,727
May 2025
2,207
Cash flows from operating activities(million JPY)
May 2021
5,183
May 2022
4,370
May 2023
4,155
May 2024
5,182
May 2025
5,897
Cash flows from investing activities(million JPY)
May 2021
-6,324
May 2022
-4,400
May 2023
-5,566
May 2024
-5,930
May 2025
-7,365
Cash flows from financing activities(million JPY)
May 2021
1,425
May 2022
989
May 2023
616
May 2024
-183
May 2025
1,002
Return on equity(%)
May 2021
10.9
May 2022
10.5
May 2023
7.3
May 2024
6.4
May 2025
3.7
Equity ratio(%)
May 2021
72.1
May 2022
72.8
May 2023
71.8
May 2024
67
May 2025
66.7
Earnings per share(JPY per share)
May 2021
282.7455
May 2022
304.9182
May 2023
227.6273
May 2024
210
May 2025
62.74
Net assets per share(JPY per share)
May 2021
2,758.9818
May 2022
3,009.4
May 2023
3,206.5
May 2024
3,404.7
May 2025
1,734.26
Dividend per share(JPY per share)
May 2021
41.8182
May 2022
54.5455
May 2023
54.5455
May 2024
60
May 2025
70
Payout ratio(%)
May 2021
14.79
May 2022
17.89
May 2023
23.96
May 2024
28.57
May 2025
111.57
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.